Do high-risk features support the use of adjuvant chemotherapy in stage II colon cancer? A Turkish Oncology Group study

ARTAÇ M., Turha N. S. , Kocer M. , KARABULUT B., Bozcuk H., Yalcin S., ...More

TUMORI J, vol.100, no.2, pp.143-148, 2014 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 100 Issue: 2
  • Publication Date: 2014
  • Doi Number: 10.1700/1491.16397
  • Title of Journal : TUMORI J
  • Page Numbers: pp.143-148


Background. A high-risk group of patients with stage II colon cancer has been identified by the results of studies in Western populations. The aim of this study was to investigate the prognostic factors of adjuvant chemotherapy in Turkish patients with stage II colon cancer.